Thomas McGarry

2.1k total citations
21 papers, 1.1k citations indexed

About

Thomas McGarry is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas McGarry has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas McGarry's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (8 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Thomas McGarry is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (8 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Thomas McGarry collaborates with scholars based in United States, New Zealand and Taiwan. Thomas McGarry's co-authors include Steven Sun, Enrico P. Veltri, Lorenzo Melani, Robert Bettis, Alexandre LeBeaut, Leslie Lipka, Ramachandran Suresh, Michael H. Davidson, Mark Turco and Jeffrey J. Popma and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Thomas McGarry

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas McGarry United States	12	899	503	253	193	159	21	1.1k
Laura H. Gardner United States	12	1.2k 1.3×	939 1.9×	294 1.2×	92 0.5×	121 0.8×	18	1.6k
Michalina Kołodziejczak Poland	17	1.2k 1.3×	782 1.6×	169 0.7×	106 0.5×	110 0.7×	30	1.6k
Tingfei Hu United States	13	826 0.9×	771 1.5×	183 0.7×	160 0.8×	105 0.7×	17	1.4k
Binh An P. Phan United States	14	469 0.5×	307 0.6×	129 0.5×	190 1.0×	124 0.8×	24	938
TJ Smilde Netherlands	3	488 0.5×	267 0.5×	86 0.3×	208 1.1×	162 1.0×	5	755
Xue-Qiao Zhao United States	18	781 0.9×	901 1.8×	432 1.7×	234 1.2×	65 0.4×	55	1.4k
Anja Vogt Germany	19	1.1k 1.2×	397 0.8×	127 0.5×	115 0.6×	234 1.5×	66	1.5k
Anton Camaj United States	14	489 0.5×	381 0.8×	106 0.4×	132 0.7×	39 0.2×	37	795
Anne B. Rossebø Norway	22	829 0.9×	1.9k 3.7×	635 2.5×	448 2.3×	200 1.3×	45	2.3k
Jeong‐Gun Park United States	18	1.0k 1.2×	587 1.2×	71 0.3×	114 0.6×	173 1.1×	59	1.6k

Countries citing papers authored by Thomas McGarry

Since Specialization

Citations

This map shows the geographic impact of Thomas McGarry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas McGarry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas McGarry more than expected).

Fields of papers citing papers by Thomas McGarry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas McGarry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas McGarry. The network helps show where Thomas McGarry may publish in the future.

Co-authorship network of co-authors of Thomas McGarry

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas McGarry. A scholar is included among the top collaborators of Thomas McGarry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas McGarry. Thomas McGarry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stuckey, Thomas, Thomas R. McMinn, Jeremiah P. Depta, et al.. (2024). Clinical Validation of a Machine-Learned, Point-of-Care System to IDENTIFY Functionally Significant Coronary Artery Disease. Diagnostics. 14(10). 987–987. 1 indexed citations

McGarry, Thomas. (2021). B-PO04-158 TROPONIN ELEVATION DURING EPISODES OF SUPRAVENTRICULAR TACHYCARDIA. Heart Rhythm. 18(8). S342–S343.

Ormiston, John A., Tift Mann, Jack Hall, et al.. (2012). Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions. Coronary Artery Disease. 24(1). 61–68. 9 indexed citations

Waksman, Ron, Magdi Ghali, Thomas Ryan, et al.. (2012). Percutaneous Coronary Intervention With Second-Generation Paclitaxel-Eluting Stents Versus Everolimus-Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial). The American Journal of Cardiology. 110(8). 1119–1124. 7 indexed citations

Cohen, David J., Tara A. Lavelle, Ben van Hout, et al.. (2011). Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial. Catheterization and Cardiovascular Interventions. 79(2). 198–209. 41 indexed citations

Kereiakes, Dean J., Louis Cannon, John A. Ormiston, et al.. (2011). Propensity-Matched Patient-Level Comparison of the TAXUS Liberté and TAXUS Element (ION) Paclitaxel-Eluting Stents. The American Journal of Cardiology. 108(6). 828–837. 11 indexed citations

Cannon, Louis, Dean J. Kereiakes, Tift Mann, et al.. (2011). A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. EuroIntervention. 6(8). 920–927. 24 indexed citations

Weissman, Neil J., Mark Turco, John A. Ormiston, et al.. (2010). Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents. Cardiovascular revascularization medicine. 12(4). 247–257. 9 indexed citations

Mahmud, Ehtisham, John A. Ormiston, Mark Turco, et al.. (2009). TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically Treated Diabetes Mellitus. JACC: Cardiovascular Interventions. 2(3). 240–252. 27 indexed citations

10.

Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2008). Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent. JACC: Cardiovascular Interventions. 1(6). 699–709. 67 indexed citations

11.

Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2007). Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions. Journal of the American College of Cardiology. 49(16). 1676–1683. 81 indexed citations

12.

Stone, Gregg W., Stephen G. Ellis, Lowell F. Satler, et al.. (2006). Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents. JAMA. 295(11). 1253–1253.

13.

Stone, Gregg W., Stephen G. Ellis, Steven L. Martin, et al.. (2006). Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.. PubMed. 295(11). 1253–63. 203 indexed citations

14.

Nikolsky, Eugenia, Edward Kosinski, Gregory Mishkel, et al.. (2005). Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). The American Journal of Cardiology. 95(6). 709–715. 50 indexed citations

15.

Najjar, Samer F., et al.. (2004). Evaluation of Poly-N-Acetyl Glucosamine as a Hemostatic Agent in Patients Undergoing Cardiac Catheterization: A Double-Blind, Randomized Study. The Journal of Trauma: Injury, Infection, and Critical Care. 57(1). S38–S41. 20 indexed citations

16.

Davidson, Michael H., Thomas McGarry, Robert Bettis, et al.. (2002). Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. Journal of the American College of Cardiology. 40(12). 2125–2134. 413 indexed citations

17.

Davidson, Michael, Thomas McGarry, Robert Bettis, et al.. (2002). Ezetimlbe co-administered With slmvastatin in 668 patients With primary hypercholesterolemia. Journal of the American College of Cardiology. 39. 226–227. 10 indexed citations

18.

McGarry, Thomas, Ronald S. Gottlieb, Joel Morganroth, et al.. (1992). The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty. American Heart Journal. 123(6). 1445–1451. 67 indexed citations

19.

Dreifus, Leonard S., Thomas McGarry, & Demetrios Kimbiris. (1963). New Concepts in the Approach to Digitalis Therapy for Atrial Fibrillation. Diseases of the Chest. 44(2). 197–200. 5 indexed citations

20.

Dreifus, Leonard S., et al.. (1962). Evaluation of the Antiarrhythmic Properties of Antazoline. The American Journal of Cardiology. 9(4). 564–567. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact